期刊文献+

麻保沙星在番鸭体内的药代动力学研究 被引量:5

Pharmacokinetics of marbofloxacin in Muscovy ducks
原文传递
导出
摘要 将30只健康番鸭随机分为3组,静脉注射、肌肉注射及内服麻保沙星(2.5mg/kg)后,采用反相高效液相色谱法测定血浆中麻保沙星的浓度,用Kinetica4.4.1药代动力学软件处理所得到的血药浓度-时间数据。结果显示,健康番鸭静脉注射给药的药时数据适合二室开放模型,主要药代动力学参数分别为:t1/2α=(0.45±0.17)h,t1/2β=(3.28±0.33)h,Vc=(0.8±0.1)L/kg,Vd(area)=(1.39±0.28)L/kg,Vd(ss)=(1.25±0.22)L/kg,Cl=(0.23±0.05)L/(h.kg),AUC=(9.24±1.35)mg/(h.L)。健康番鸭肌肉注射给药的药时数据适合一级吸收一室开放模型,主要药代动力学参数分别为:t1/2ka=(0.16±0.06)h,t1/2kel=(2.82±0.36)h,tmax=(0.59±0.11)h,Cmax=(1.8±0.29)μg/mL,AUC=(7.92±1.09)mg/(h.L),F=(90.4±1.73)%。健康番鸭内服给药的药时数据适合一级吸收一室开放模型,主要药代动力学参数分别为:t1/2ka=(0.34±0.09)h,t1/2kel=(4.61±0.57)h,tmax=(1.41±0.3)h,Cmax=(1.13±0.21)μg/mL,AUC=(8.8±1.15)mg/(h.L),F=(96.98±5.16)%。结果表明,麻保沙星在健康番鸭体内的药代动力学特征是:吸收迅速且完全,分布广泛,消除缓慢,组织渗透力强,生物利用度高。 Thirty Muscovy ducks were randomly assigned to three groups of 10 ducks each for the sin-gle intravenous(IV) ,intramuscular(IM) or stomach tube(ST) administrations at a dose of 2.5 mg/kg mar-bofloxacin according to duck body weight. The marbofloxacin concentration in plasma was determined by high performance liquid chromatography with UV. The data were analyzed with the pharmacokinetics com-puter program Kinetica4. 4.1. In results, the relationship of concentration-time was fitted to a two-compart-ment open model after single Ⅳ dosing in healthy Muscovy ducks. The main pharmacokinetic parameters were as follows:t_(1/2α)=(0.45±0.17)h,t_(1/2β)=(3.28±0.33)h,V_c=(0.8±0.1)L/kg,V_(d(area))=(1.39± 0.28)L/kg,V_(d(ss)))=(1.25±0.22)L/kg,Cl=(0.23±0.05)L/(h·kg),AUC=(9.24±1.35)mg/(h·L). The concentration-time relationship was fitted to a mono-compartment open model with first-order absorp-tion after single IM dosing in healthy Muscovy ducks. The main pharmacokinetic parameters were as fol-lows:t_(1/2k_α)(0.12±0.06)h,t_(1/2k_(el))=(2.82±0.36)h,t_(max)=(0.59±0.11)h,C_(max)(1.8±0.29)μg/mL, to a mono-compartment open model with first-order absorption after single ST dosing in healthy Muscovy ducks. The main pharmacokinetic parameters were as follows:t_(1/2k_α)=(0.34±0.09)h,t_(1/2k_(el))=(4.61±0.57)h, The results showed that the pharmacokinetic characteristics of marbofloxacin in healthy Muscovy ducks manifested rapid and complete absorption, wide distribution and slow elimination, good tissue penetration and high bioavailability.
出处 《中国兽医科学》 CAS CSCD 北大核心 2010年第1期89-92,共4页 Chinese Veterinary Science
基金 国家自然科学基金项目(30771629)
关键词 麻保沙星 药代动力学 生物利用度 番鸭 marbofloxacin pharmacokinetics bioavailability Muscovy duck
  • 相关文献

参考文献16

  • 1陈军,张淑华.氟喹诺酮类抗菌药马波沙星的研究进展[J].中国兽药杂志,2006,40(12):38-43. 被引量:13
  • 2王志强,陈杖榴.动物专用氟喹诺酮为抗菌新药——麻保沙星[J].中兽医医药杂志,2001,20(4):38-41. 被引量:24
  • 3ANADON A,MARTINEZ-LARRANAGA M R,DIAZ M J,et al.Pharmacokinetie characteristics and tissue residues for marbofloxacin and its metabolite N-desmethyl-marbofloxacin in broiler chickens[J].Am J Vet Res,2002,63(7):927-933.
  • 4HARITOVA A M,RUSENOVA N V,PARVANOVA P P,et al.Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys[J].Antimicrob Agents Chemother,2006,50(11):3779-3785.
  • 5黄显会,陈杖榴,张淑婷,曾振灵.麻保沙星(marbofloxacin)在鸡体内的生物利用度及药物动力学[J].中国兽医学报,2002,22(3):279-281. 被引量:15
  • 6DE LUCAS J J,RODRIGUEZ C,WAXMAN S,et al.Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration to ostriches[J].Vet J,2005,170(3):364-368.
  • 7HUNTER R P,KOCH D E,COKE R L,et al.Identification and comparison of marbofloxacin metabolitcs from the plasma of ball pythons (Python regius) and blue and gold macaws (Ara ararauna)[J].J Vet Pharmacol Ther,2007,30(3):257-262.
  • 8KNOLL U,GL(U)NDER G,KIETZMANN M.Comparative study of the pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens[J].J Vet Pharmacol Ther,1999,22(4):239-246.
  • 9GARC(I)A-MONTIJANO M,WAXMAN S,SANCHEZ C,et al.The disposition of marbofloxacin in Eurassian buzzards (Buteo buteo) after intravenous administration[J].J Vet Pharmacol Ther,2001,24(2):155-157.
  • 10HOOPER D C,WOLFSON J S.Quinolone Antimicrobial Agents[M].Washington DC:American Society for Microbiology,1993.

二级参考文献33

  • 1宋冶萍,陈杖榴.鸡静注、肌注及内服氟哌酸的药物动力学研究[J].畜牧兽医学报,1995,26(1):65-70. 被引量:11
  • 2曾振灵,冯淇辉.兽用氟喹诺酮类药物研究与临床应用进展[J].中国兽医科技,1995,25(3):39-41. 被引量:32
  • 3夏文江 成章瑞.MCPKP-药物动力学室分析的一种微机程序[J].中国药理学报,1988,9:188-188.
  • 4Sally G. Quinolones : A Class of Antimicrobial Agents [ J ]. Vet Med-Czech, 2001,46(9/10) : 257 -274.
  • 5Drlica K, Zhao X. DNA Gyrase, Topoisomerase Ⅳ, and the 4-Quinolones[J]. Microbiol Mol Biol Rev, 1997, 61 (3) : 377 -392.
  • 6Bousquet-Melou A, Bernard S, Schneider M, et al. Pharmacokinetics of Marbofloxacin in Horses [ J ]. Equine Vet J, 2002, 34(4) : 366 -372.
  • 7Schneider M, Valle M, Woehrle F, et al. Pharmacokinetics of Marbofloxacin in Lactating Cows after Repeated Intramuscular Administrations and Pharmaeodynamics Against Mastitis Isolated Strains[J]. J Dairy Sci, 2004, 87(1): 202 -211.
  • 8Dubreuil L, Houcke I, Leroy I. In vitro Activity of a New Fluoroquinolone, Marbofloxacin ( RO 09 - 1168 ) against Strictly Anaerobic Bacteria and Some Bacteria from Human Fecal Flora [ J ].Pathol Biol (Paris) ,1996, 44 (5):333 - 336.
  • 9Seol B.Comparative in vitro Activities of Enrofloxaein, Ciprofloxacin and Marbofloxacin against Staphylococcus intermedius Isolated from Dogs[J].Vet Arhiv, 2005, 75 (3): 189-194.
  • 10Spreng M, Deleforge J, Thomas V, ct al. Antibacterial Activity of Marbofloxacin: a New Fluoroquinolone for Veterinary Use against Canine and Feline Isolates[J]. J Vet Pharmacol Ther. 1995, 18(4): 284 -289.

共引文献38

同被引文献36

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部